Details of the Active Pharmaceutical Ingredient (API)
| General Information of API (ID: D00313) | |||||
|---|---|---|---|---|---|
| Name |
Hydrocodone
|
||||
| Synonyms |
Click to Show/Hide the Synonyms of This API
HYDROCODONE; Dihydrocodeinone; Hydrocodon; Hydrocone; Hydroconum; Codinovo; Dicodid; Bekadid; Idrocodone; Idrocodone [DCIT]; (-)-Dihydrocodeinone; hidrocodona; Hydrocodonum; Hydrocodonum [INN-Latin]; 125-29-1; Hidrocodona [INN-Spanish]; Multacodin; Codeinone, dihydro-; UNII-6YKS4Y3WQ7; 4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one; 6-Oxo-3-methoxy-N-methyl-4,5-epoxymorphinan; 4,5alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one; 6YKS4Y3WQ7; Zohydro; CHEBI:5779; NSC 19044; Hydrocodone [INN:BAN]; (4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one; Hydrocodone polistirex; 50678-79-0; Hydrocodone (INN); HSDB 3097; NCGC00159317-02; EINECS 204-733-9; 4,5.alpha.-Epoxy-3-methoxy-17-methylmorphinan-6-one; BRN 0094193; opioid1; DEA No. 9193; SCHEMBL2987; CHEMBL1457; 4-27-00-03580 (Beilstein Handbook Reference); 3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one; Hydrocodone polistirex [USAN]; GTPL7081; DTXSID8023131; Morphinan-6-one, 4,5-alpha-epoxy-3-methoxy-17-methyl-; (5alpha)-17-methyl-3-(methyloxy)-4,5-epoxymorphinan-6-one; Hydrocodone 0.1 mg/ml in Methanol; Hydrocodone 1.0 mg/ml in Methanol; NSC19044; ZINC1280665; BDBM50386689; NSC-19044; DB00956; NCGC00159317-03; C08024; D08045; Q411441; 17-methyl-4,5alpha-epoxy-3-methoxymorphinan-6-one; 4,5alpha-epoxy-3-methoxy-17-methyl-morphinan-6-one; Morphinan-6-one,5.alpha.-epoxy-3-methoxy-17-methyl-; Morphinan-6-one, 4,5alpha-epoxy-3-methoxy-17-methyl- (8CI); Morphinan-6-one,5-epoxy-3-methoxy-17-methyl-, (5.alpha.)-; WLN: T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ JO1 P1; Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)- (9CI); 4aH-8,5-bcd]furan-5-(6H)-one, 7,7a,8,9-tetrahydro-3-methoxy-12-methyl-; (1S,5R,13R,17R)-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
|
||||
| Clinical Status |
Approved
|
||||
| Disease Indication | Anaesthesia | ICD-11: 8E22 | [1] | ||
| PubChem CID | |||||
| Formula |
C18H21NO3
|
||||
| Canonical SMILES |
CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4
|
||||
| InChI |
1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1
|
||||
| InChIKey |
LLPOLZWFYMWNKH-CMKMFDCUSA-N
|
||||
| Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5284569"></iframe>
|
![]() |
|||
| 3D MOL | 2D MOL | ||||
| Physicochemical Properties | Molecular Weight | 299.4 | Topological Polar Surface Area | 38.8 | |
| XlogP | 2.2 | Complexity | 509 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 1 | ||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | ||
| Full List of Drug Formulations (DFMs) Containing This API | ||||||
|---|---|---|---|---|---|---|
| Hydrocodone 20 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Cochineal; Fd&c blue no. 2; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
| Caprylic acid | DIG Info | GPCR84 receptor (Ki = 19600 nM) | [4] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 100 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Fd&c blue no. 2; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [3] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 40 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 60 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 30 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 80 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 120 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxytoluene; Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Polysorbate 80; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Polyethylene glycols
|
|||||
| Dosage Form | Abuse-Deterrent 24 HR Extended Release Oral Tablet | |||||
| Company | Purdue Pharma | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Butylated hydroxytoluene | DIG Info | Carbonic anhydrase II (Ki = 630 nM) | [2] | |||
| Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [3] | |||
| Polyvinyl alcohol | DIG Info | Debrisoquine 4-hydroxylase (EC50 = 354.8 uM) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Polyethylene glycol 3350 | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
| Hydrocodone 10 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Hydrocodone 15 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Hydrocodone 20 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Hydrocodone 30 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Hydrocodone 40 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Hydrocodone 50 mg capsule | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Starch, corn
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 2 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin; Hypromelloses; Polyethylene glycols; Povidones
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Zogenix | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Drug Formulation 3 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Fd&c blue no. 1; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Fd&c red no. 3; Silicon dioxide; Ammonio methacrylate copolymer type b; Gelatin, unspecified; Hypromellose, unspecified; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
| Dosage Form | 12 HR Extended Release Oral Capsule | |||||
| Company | Pernix Therapeutics | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [3] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [7] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [7] | |||
| FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [3] | |||
| Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


